Lv1
80 积分 2023-12-02 加入
Heterogeneity of immunostaining for tumour markers in non-small cell lung carcinoma
2个月前
已完结
Clinical and translational attributes of immune-related adverse events
2个月前
已完结
The next generation of immunotherapies for lung cancers
2个月前
已完结
The new era of lung cancer therapy: Combining immunotherapy with ferroptosis
2个月前
已完结
EPR26-163: The Epidemiology of Second Primary Lung Cancer: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Program
3个月前
已关闭
Noninvasive Method for Predicting the Expression of Ki67 and Prognosis in Non-Small-Cell Lung Cancer Patients: Radiomics
3个月前
已完结
Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer
4个月前
已完结
Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients
4个月前
已完结
Non–Small Cell Lung Cancer, Version 4.2024
4个月前
已完结
The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patients
4个月前
已完结
皖公网安备34019202002308
